pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 9·1 min read
save

HHS proposes new rule to compensate Covid-19 vaccine injury claims

Jul 9, 2026·read at Endpoints ↗RegulatoryNeutral

The U.S. Department of Health and Human Services has issued a proposed rule that would create a compensation mechanism for people who say they were injured by Covid-19 vaccines.

The new system is intended to operate while the Vaccine Injury Compensation Program’s oversight panel remains without appointed members, leaving the existing process in limbo.

Under the proposal, claimants could file for payments through the new mechanism, though the rule does not yet detail the amount of funding or specific eligibility criteria.

The move reflects ongoing efforts to address vaccine injury concerns and could affect how future vaccine-related claims are handled.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “HHS advances plan to pay out Covid-19 vaccine injury claims”

read at Endpoints ↗
93 words · retrieved Jul 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Coronavirus Disease 2019 (COVID-19) vaccineCoronavirus Disease 2019 (COVID-19) vaccine 1
topics
Vaccine5Vaccines2

related stories

  • 3d agoA winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 26Kennedy posts vaccine misinformation, spars on social media amid measles deathsSTAT
  • Aug 19Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goalBioSpace
  • Aug 19Moderna and Merck cancer vaccine returns ‘landmark’ result in melanomaBioPharma Dive
  • Aug 11Trump signs order seeking to upend childhood vaccine scheduleBioPharma Dive